Correlation Between Teva Pharma and Artelo Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Teva Pharma and Artelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharma and Artelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Teva Pharma Industries and Artelo Biosciences, you can compare the effects of market volatilities on Teva Pharma and Artelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharma with a short position of Artelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharma and Artelo Biosciences.

Diversification Opportunities for Teva Pharma and Artelo Biosciences

TevaArteloDiversified AwayTevaArteloDiversified Away100%
0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Teva and Artelo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharma Industries and Artelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artelo Biosciences and Teva Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharma Industries are associated (or correlated) with Artelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artelo Biosciences has no effect on the direction of Teva Pharma i.e., Teva Pharma and Artelo Biosciences go up and down completely randomly.

Pair Corralation between Teva Pharma and Artelo Biosciences

Given the investment horizon of 90 days Teva Pharma Industries is expected to generate 1.79 times more return on investment than Artelo Biosciences. However, Teva Pharma is 1.79 times more volatile than Artelo Biosciences. It trades about 0.22 of its potential returns per unit of risk. Artelo Biosciences is currently generating about -0.24 per unit of risk. If you would invest  1,703  in Teva Pharma Industries on September 21, 2024 and sell it today you would earn a total of  506.00  from holding Teva Pharma Industries or generate 29.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Teva Pharma Industries  vs.  Artelo Biosciences

 Performance 
JavaScript chart by amCharts 3.21.15OctNovDec -5051015
JavaScript chart by amCharts 3.21.15TEVA ARTL
       Timeline  
Teva Pharma Industries 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharma Industries are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Teva Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15OctNovDecNovDec171819202122
Artelo Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Artelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
JavaScript chart by amCharts 3.21.15OctNovDecNovDec0.9511.051.11.151.21.251.3

Teva Pharma and Artelo Biosciences Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-11.73-8.78-5.84-2.890.03.026.099.1612.24 0.0150.0200.025
JavaScript chart by amCharts 3.21.15TEVA ARTL
       Returns  

Pair Trading with Teva Pharma and Artelo Biosciences

The main advantage of trading using opposite Teva Pharma and Artelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharma position performs unexpectedly, Artelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artelo Biosciences will offset losses from the drop in Artelo Biosciences' long position.
The idea behind Teva Pharma Industries and Artelo Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon